On September 11, according to information from Bailian Zhigao Capital, recently, Jiangsu Handian Biotechnology Co., Ltd. announced the completion of strategic financing of tens of millions of yuan. This round of financing is exclusively invested by Bailian Zhigao Capital. The funds will mainly be used to upgrade the R&D and innovation system, the layout of global intelligent manufacturing bases, and the construction of a cross-border supply chain system.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.